REGistry of Long-term AnTithrombotic TherApy-2

Recruiting now

Conditions studied: Atrial Fibrillation

In brief

To assess the rates of ischemic and hemorrhagic complications of long-term antithrombotic therapy in patients with atrial fibrillation

Key facts

Study ID

NCT04347187

Run by

National Medical Research Center for Cardiology, Ministry of Health of Russian Federation

People needed

2000

Starts

2015-01-15

Expected to finish

2026-12-31

Last updated by the study team

2026-05-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Documented atrial fibrillation with CHA2DS2VASC > 1

You may not qualify if…

• Subjects who are unwilling or unable to provide informed consent. ACS within 12 months before inclusion Severe CHF (NYHA IV) Stroke within 6 months before inclusion Severe liver or muscle disease Severe kidney disease / renal failure with creatinine > 3 mg/dl Conceivable impossibility to come in touch with the patient or his family at 1-year after the intervention

Where it is running

• National Medical Research Center for Cardiology, Ministry of Health of Russian Federation — Moscow, Russia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.